Pan-cancer analysis highlights the role of PSENEN in the prognosis and immunology of cancer
Background: Presenilin enhancer-2 (PSENEN, PEN-2), one of the four components of the γ-secretase complex, has been increasingly revealed to be significant in cancer types such as pancreatic cancer, gastric cancer, and breast cancer. However, the pan-cancer clinical relevance of PSENEN remains unclea...
Saved in:
Main Authors: | Zerui YANG (Author), Dingsheng WEN (Author), Yubing YE (Author), Kai CHEN (Author), Zhikun QIU (Author), Xingyun LIU (Author), Xiong LI (Author) |
---|---|
Format: | Book |
Published: |
KeAi Communications Co., Ltd.,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The prognostic and immunological role of MCM3 in pan-cancer and validation of prognosis in a clinical lower-grade glioma cohort
by: Qian-Rong Huang, et al.
Published: (2024) -
Immunological role and prognostic value of SPARCL1 in pan-cancer analysis
by: Kangwei He, et al.
Published: (2022) -
PSENEN mutation in coexistent hidradenitis suppurativa and dowling-degos disease
by: Dincy C. V Peter, et al.
Published: (2021) -
Prognostic implication and immunological value of contactin 1 expression in pan‐cancer
by: Lingyun Zhang, et al.
Published: (2022) -
The role of ARL4C in predicting prognosis and immunotherapy drug susceptibility in pan-cancer analysis
by: Hanshu Zhao, et al.
Published: (2023)